Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Orgenesis (ORGS) just unveiled an announcement.
During Orgenesis Inc.’s 2024 annual stockholders’ meeting, a key amendment was approved to increase shares for award grants by 9 million under their Equity Incentive Plan. Additionally, stockholders elected five director nominees to serve until the next annual meeting. Notably, board members Yachin, Sidransky, and Philips concluded their terms without re-election, and Kevin Choquette withdrew his director nomination. The company’s independent auditor for the upcoming fiscal year was also ratified, with all proposals receiving the necessary votes for approval.
For detailed information about ORGS stock, go to TipRanks’ Stock Analysis page.
